A detailed history of California State Teachers Retirement System transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 56,004 shares of XENE stock, worth $2.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,004
Previous 58,140 3.67%
Holding current value
$2.34 Million
Previous $2.27 Million 2.78%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.12 - $43.96 $77,152 - $93,898
-2,136 Reduced 3.67%
56,004 $2.2 Million
Q2 2024

Aug 14, 2024

BUY
$36.25 - $43.75 $60,283 - $72,756
1,663 Added 2.94%
58,140 $2.27 Million
Q1 2024

May 15, 2024

BUY
$42.66 - $50.04 $20,903 - $24,519
490 Added 0.88%
56,477 $2.43 Million
Q4 2023

Feb 13, 2024

BUY
$28.7 - $46.46 $316,761 - $512,779
11,037 Added 24.55%
55,987 $2.58 Million
Q3 2023

Nov 14, 2023

BUY
$34.16 - $39.73 $19,641 - $22,844
575 Added 1.3%
44,950 $1.54 Million
Q2 2023

Aug 21, 2023

BUY
$34.84 - $43.54 $110,338 - $137,891
3,167 Added 7.69%
44,375 $1.71 Million
Q1 2023

May 09, 2023

BUY
$33.46 - $40.35 $19,172 - $23,120
573 Added 1.41%
41,208 $1.47 Million
Q4 2022

Feb 14, 2023

BUY
$33.06 - $39.43 $42,581 - $50,785
1,288 Added 3.27%
40,635 $1.6 Million
Q3 2022

Nov 18, 2022

BUY
$30.79 - $39.82 $9,729 - $12,583
316 Added 0.81%
39,347 $1.42 Million
Q2 2022

Aug 15, 2022

BUY
$25.44 - $35.16 $100,335 - $138,671
3,944 Added 11.24%
39,031 $1.19 Million
Q1 2022

May 16, 2022

BUY
$25.09 - $33.13 $39,617 - $52,312
1,579 Added 4.71%
35,087 $1.07 Million
Q4 2021

Feb 15, 2022

BUY
$15.6 - $35.4 $158,776 - $360,301
10,178 Added 43.63%
33,508 $1.05 Million
Q3 2021

Nov 15, 2021

BUY
$14.86 - $19.45 $346,683 - $453,768
23,330 New
23,330 $356,000

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.6B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.